ARLG investigator, Executive Committee Member, and Innovations Working Group Chair, Helen Boucher, MD, FACP, FIDSA, will present this year’s Maxwell Finland Lecture during IDWeek 2022 in Washington, D.C. Her presentation, “Running to Stand Still: Progress and Perils with AMR”, will highlight the key drivers of antimicrobial resistance and the potential incentives of drug and diagnostic development to treat and detect antimicrobial-resistant infections.
Dr. Boucher is the director of the Tufts Center for Integrated Management of Antimicrobial Resistance and the director of the Infectious Diseases Fellowship Program at Tufts Medical Center. Dr. Boucher has held several other leadership positions in the field of infectious diseases and has authored or co-authored numerous publications. Her research focuses on
The Maxwell Finland Lecture is awarded annually to experts who have contributed to the areas of bacterial pathogenesis, antimicrobial agents, emerging infections, and hospital-acquired infections. It is named in honor of IDSA’s first president, Maxwell Finland, MD, DSci, who was internationally recognized for his work on the incidence and character of infectious diseases and their treatments.
Dr. Boucher will deliver her lecture on Thursday, October 20 at 9:15 a.m. It will be available after the event on-demand through March 2023.
See the full list of IDWeek 2022 ARLG presenters